CLYM stock

Climb Bio Inc (CLYM) financials · $85.8M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Climb Bio Inc (CLYM) $85.8M cap.

Cached annual income statement
LineFY2025FY2024
RevenueN/A$8.13M
Operating Income-$67.9M-$82.0M
Net Income-$59.9M-$73.9M
EPS (Diluted)-$0.88-$1.53
Cached annual balance sheet
LineFY2025FY2024
Total Assets$167.7M$217.2M
Current Assets$105.8M$154.9M
Cash & Equivalents$35.7M$87.2M
PP&E$288.0K$199.0K
Total Liabilities$7.27M$5.31M
Current Liabilities$6.98M$4.93M
Shareholders' Equity$160.5M$211.9M
Retained Earnings-$289.7M-$229.9M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$54.4M-$15.6M
CapEx$186.0KN/A
Investing Cash Flow$2.83M-$121.1M
Financing Cash Flow-$21.0K$130.7M
Net Change in Cash-$51.5M-$5.88M
Free Cash Flow-$54.5M-$15.6M
These statements as JSON? API free 100/day

FAQ

What is CLYM P/E and revenue?

Climb Bio Inc (CLYM) $85.8M cap.

What is CLYM revenue?

CLYM income-statement cache has no revenue figure yet.

Is CLYM profitable?

Climb Bio Inc last cached net income is -$59.9M (FY2025).

What are CLYM total assets?

Climb Bio Inc last cached total assets are $167.7M (FY2025).

What is CLYM free cash flow?

Climb Bio Inc last cached free cash flow is -$54.5M (FY2025).

Not investment advice. Cached statements, not a live tape.